EBV Infection

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study

Zuberitamab for EBV Infection Post-Allo-HSCT

EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

Investigating Epstein-Barr Virus Associated Conjunctivitis

Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection

Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection

Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT

A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Nasopharyngeal Carcinoma.

Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric Carcinogenesis

Study on the Application of Saliva EBV-DNA Detection in EBV Infection Related Diseases

PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV

Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line Therapy

PD-1 Antibody for Reactive EBV After BMT

Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL)

Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)